Next report date
Report period
Q2 2024
EPS estimate
0.07EUR
Revenue estimate
265.88 MEUR
0.26EUR
259.75 MEUR
946.46 MEUR
123.13 M
About HANGZHOU TIGERMED
Sector
CEO
Xiao Chun Cao
Website
Headquarters
Hangzhou
Employees (FY)
9.7 K
Founded
2004
ISIN
CNE1000040M1
FIGI
BBG011FHLGR4
Hangzhou Tigermed Consulting Co., Ltd. provides clinical research services for research and development of domestic and foreign pharmaceutical and health related products. Its services include technical services for phase I to phase IV clinical trials, registration and declaration of clinical trials, on-site services, as well as data management and analysis, etc. The company was founded on December 15, 2004 and is headquartered in Hangzhou, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange HANGZHOU TIGERMED CO. H 1 stocks are traded under the ticker 5HZ1.
HANGZHOU TIGERMED CO. H 1 is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
5HZ1 earnings for the last quarter are 0.02 EUR per share, whereas the estimation was 0.06 EUR resulting in a −64.78% surprise. The estimated earnings for the next quarter are 0.07 EUR per share. See more details about HANGZHOU TIGERMED CO. H 1 earnings.
HANGZHOU TIGERMED CO. H 1 revenue for the last quarter amounts to 250.34 M EUR despite the estimated figure of 256.65 M EUR. In the next quarter revenue is expected to reach 237.07 M EUR.
Yes, you can track HANGZHOU TIGERMED CO. H 1 financials in yearly and quarterly reports right on TradingView.
5HZ1 net income for the last quarter is 30.28 M EUR, while the quarter before that showed 18.21 M EUR of net income which accounts for 66.25% change. Track more HANGZHOU TIGERMED CO. H 1 financial stats to get the full picture.
Yes, 5HZ1 dividends are paid annually. The last dividend per share was 0.07 EUR. As of today, Dividend Yield (TTM)% is 1.83%. Tracking HANGZHOU TIGERMED CO. H 1 dividends might help you take more informed decisions.
HANGZHOU TIGERMED CO. H 1 dividend yield was 1.77% in 2023, and payout ratio reached 21.94%. The year before the numbers were 0.77% and 22.70% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 5HZ1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANGZHOU TIGERMED CO. H 1 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 29, 2024, the company has 9.70 K employees. See our rating of the largest employees — is HANGZHOU TIGERMED CO. H 1 on this list?
We've gathered analysts' opinions on HANGZHOU TIGERMED CO. H 1 future price: according to them, 5HZ1 price has a max estimate of 10.70 EUR and a min estimate of 3.90 EUR. Read a more detailed HANGZHOU TIGERMED CO. H 1 forecast: see what analysts think of HANGZHOU TIGERMED CO. H 1 and suggest that you do with its stocks.